Alpha Cognition Inc.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
02074J501
SEDOL
N/A
CIK
N/A
LEI:
FIGI: BBG00L7TXMM3
ACOG
Alpha Cognition Inc.
GICS: -
·
Sektor: EQTY
·
Sub-Sektor: -
NAME
Alpha Cognition Inc.
ISIN
CA02074J5017
TICKER
ACOG
MIC
XNAS
REUTERS
ACOG.OQ
BLOOMBERG
ACOG US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 06.01.2025
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced it will host an investor update call on Tuesday, January 28th, 2025 at 4pm EST to present its commercial launch strategy for ZUNVEYL (benzgalant...
Alpha Cognition
Mo., 16.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced that the underwriters of its underwritten U.S. public offering (the “Offering”) have partially exercised their over-allotment option to purchase...
Alpha Cognition
Fr., 13.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq Capital Market the Company will voluntarily delist its common shares from the Canadian Securities Exchange.
The shares will be delisted from the Canadian Securities Exchange at the close of trading on D...
Alpha Cognition
Mi., 11.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced interim preclinical data that supports the continued development of ALPHA-1062 for the treatment of mild traumatic brain injury (mTBI). The...
Alpha Cognition
Informationen zu Product Placements
SMART * AD
P R O D U C T S U G G E S T I O N S
